Amoebal Endosymbiont Protochlamydia Induces Apoptosis to Human Immortal HEp-2 Cells by Ito, Atsushi et al.
Amoebal Endosymbiont Protochlamydia Induces
Apoptosis to Human Immortal HEp-2 Cells
Atsushi Ito
1, Junji Matsuo
1, Shinji Nakamura
2, Asahi Yoshida
1, Miho Okude
1, Yasuhiro Hayashi
1, Haruna
Sakai
2, Mitsutaka Yoshida
3, Kaori Takahashi
3, Hiroyuki Yamaguchi
1*
1Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan, 2Division of Biomedical Imaging Research,
Juntendo University Graduate School of Medicine, Tokyo, Japan, 3Division of Ultrastructural Research, Juntendo University Graduate School of Medicine, Tokyo, Japan
Abstract
Protochlamydia, an environmental chlamydia and obligate amoebal endosymbiotic bacterium, evolved to survive within
protist hosts, such as Acanthamobae, 700 million years ago. However, these bacteria do not live in vertebrates, including
humans. This raises the possibility that interactions between Protochlamydia and human cells could induce a novel
cytopathic effect, leading to new insights into host-parasite relationships. Therefore, we studied the effect of
Protochlamydia on the survival of human immortal cell line, HEp-2 cells and primary peripheral blood mononuclear cells
(PBMC). Using mainly 49,6-diamidino-2-phenylindole staining, fluorescent in situ hybridization, transmission electron
microscopy, and also TUNEL and Transwell assays, we demonstrated that the Protochlamydia induced apoptosis in HEp-2
cells. The attachment of viable bacterial cells, but not an increase of bacterial infectious progenies within the cells, was
required for the apoptosis. Other chlamydiae [Parachlamydia acanthamoebae and Chlamydia trachomatis (serovars D and
L2)] did not induce the same phenomena, indicating that the observed apoptosis may be specific to the Protochlamydia.
Furthermore, the bacteria had no effect on the survival of primary PBMCs collected from five volunteers, regardless of
activation. We concluded that Protochlamydia induces apoptosis in human-immortal HEp-2 cells and that this
endosymbiont could potentially be used as a biological tool for the elucidation of novel host-parasite relationships.
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Introduction
Chlamydiae were once considered a group of closely related
bacteria comprising many important human and animal patho-
gens that have a recurrent developmental cycle between the
elementary body (EB) and reticulate body (RB) forms in inclusion
body surrounding by membrane vesicle [1,2]. These bacteria, now
so-called pathogenic chlamydiae, can cause a variety of diseases
such as pneumoniae, trachoma, and urogenital tract infections,
which are a major cause of female infertility [3]. Chlamydia
trachomatis is the most frequently sexually transmitted bacterial
pathogen worldwide, with over 90 million new cases of infection
per year [4,5]. Chlamydophila pneumoniae is implicated in several
chronic diseases, including atherosclerosis [6] and central nervous
system diseases such as Alzheimer’s disease and multiple sclerosis
[7]. All of the pathogenic chlamydiae species have co-evolved with
their vertebrate hosts, including humans, over the past 700 million
years. Such relationships between these bacteria and their hosts
are therefore postulated to be symbiotic. Stable and exclusive host-
parasite relationships have developed through a decrease in
genome size and loss of redundant genes, resulting in a shift to
parasitic energy and metabolic requirements and genomes of
approximately 1.0–1.2 Mb [8,9,10]. This gene reduction is
potentially a strategy to efficiently escape from the host-immune
network [8,9,10]. The complicated mechanism between patho-
genic chlamydiae and host cells are becoming more obvious. It is
the striking view that chlamydial type III effector proteins,
inclusion membrane proteins (Incs) are deeply responsible for a
process of inclusion biogenesis [11]. Furthermore, while the
pathogenic chlamydiae also possess chlamydia protease-like
activating factor (CPAF) causing modification of cellular function
[12] and actin-recruiting protein Tarp [13], it is a notable thing
that these bacteria have chlamydia protein associating with death
domains, inducing apoptosis in variety of mammalian cell lines
[14].
Several chlamydia-like endosymbionts of amoebae, inhabiting
environments including pond water, soil and sewage, were
discovered in the late 1990s, demonstrating the existence of a
broad range of chlamydiae in diverse natural habitats [15,16].
Numerous new chlamydial organisms, including the so-called
environmental chlamydiae, have now been assigned to the new
families Parachlamydiaceae, Simkaniaceae and Waddliaceae [17]. While
these environmental chlamydiae have a developmental cycle
similar to the pathogenic chlamydiae, they differ in that they
evolved to live with a protist host, such as amoebae, some 700
million years ago [10]. In addition, the genome of environmental
chlamydia Protochlamydia UWE25 is not in the process of becoming
smaller and has stabilized at 2.4 Mb [10]. This implies that to
overcome stressful conditions, the environmental chlamydiae still
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30270possess certain molecules that the pathogenic chlamydiae have
lost. It is also possible that interactions between these bacteria and
human cells could induce novel cytopathic effects, leading to new
insights into host-parasite relationships.
The family Parachlamydiaceae, consisting of Parachlamydia acantha-
moebae, Neochlamydia hartmanellae and Protochlamydia amoebophila has
well documented as representative environmental chlamydiae that
show a wide distribution range in natural environments, such as in
rivers and soil [10,15,17]. In particular, it is well known that P.
acanthamoebae infects and to a limited degree multiplies in human
cell lines such as monocyte-derived macrophages, pneumocytes,
and lung fibroblasts [18,19,20], and the bacteria has been
implicated primarily in community-aquired pneumonia, bronchi-
tis, and aspiration pneumoniae [21,22]. Recently, it has also been
reported that Protochlamydia is a potential etiological agent of
human pneumoniae [23], although the association of the
Protochlamydia with human cells possibly causing cellular function
such as cell death remains unknown.
We previously isolated five Acanthamoeba strains from river and
soil samples in Sapporo, Japan, which were persistently infected
with the endosymbiotic bacteria a-Proteobacteria and b-Proteobacteria,
and environmental chlamydiae including Neochlamydia and Proto-
chlamydia [24,12]. Our data indicated that the viability of all
endosymbionts isolated from the amoebae rapidly decreased after
10 to 24 hours and lost the ability to be transferred to other
amoebae strains [24,25]. This indicated a stable symbiotic
relationship between the host amoebae and these bacterial species.
As mentioned above, Protochlamydia is likely to have retained many
fuctional molecules, which pathogenic chlamydiae have already
lost as a consequence of adaptation to a stable host environment.
In the present study, we therefore assessed the potential induction
of apoptosis by the amoebal endosymbiont Protochlamydia on the
human immortal cell lines, HEp-2, and primary peripheral blood
mononuclear cells (PBMC), offering new insight into host-parasite
relationships and the development of novel strategy for removing
cells persistent infected with pathogens.
Results
Effect of bacterial treatment on human immortal HEp-2
cell morphology
We first assessed whether Protochlamydia could induce phenotypic
alternation, such as cell death, in human immortal HEp-2 cells.
HEp-2 cell morphology altered to include blebbing (Fig. 1A) and
cellular detachment (Fig. 1C), after being incubated with the
bacteria for 24 h. This indicated morphological traits of cell death,
such as apoptosis. Cell viability was further confirmed using a
trypan blue exclusion assay (data not shown). The prevalence of
dead cells started to increase by approximately 20% at 6 h after
incubation, and reached approximately 60–80% at 24 h after
incubation. Since morphological changes peaked at MOI 90 (Fig.
S1), the bacterial inoculation rate of this MOI was therefore used
for the following experiments. The bacteria used for inoculations
were observed to be viable as they were still capable of infecting
the amoebae, which are natural host cells for Protochlamydia
(Fig. 1B). These results strongly suggested that the cell death of
HEp-2 cells induced by the inoculated Protochlamydia was apoptosis.
Evaluation of the cell death as apoptosis
To assess the possibility of apoptotic cell death, we determined if
the traits of this cell death were identical to the criteria of apoptosis
using the TUNEL assay. Specific fluorescence spots on the
cultured cells were observed in the presence of Protochlamydia and
staurosporine (a positive control for apoptosis), demonstrating that
the Protochlamydia-induced cell death was apoptosis (Fig. 2A). The
prevalence of specific spots significantly increased with time over
on the 24 h culture period (Fig. 2B). Similar morphological
changes were also observed for the cells cultured with staurospor-
ine, along with identical cell death rates as estimated using 49,6-
diamidino-2-phenylindole (DAPI) staining (Fig. 2B). It was also
confirmed that the prevalence of dead cells was significantly
inhibited by the treatment with a general caspase inhibitor Z-
VAD-FMK, which is a cell-permeant pan caspase inhibitor
(Fig. 2C) and a specific caspase-3 inhibitor Z-DEVD-FMK
(Fig. 2D), respectively, suggesting that the cell deaths is unlikely
to be pyroptosis without caspase-3 activation [14]. Although
unusual in some features the transmission electron microscopy
(TEM) morphology was consistent with cell death apoptosis
(Fig. 3). We also confirmed that Protochlamydia could induce
apoptosis in other mammalian immortal cells, including Vero,
Jurkat and THP-1 cells (Fig. S2). Thus, these results indicated that
the cell death on HEp-2 cells induced by the inoculation of
Protochlamydia was apoptosis. Since apoptotic cells could easily be
identified with DAPI staining, this staining method was used in all
subsequent HEp-2 cell experiments to estimate the prevalence of
apoptotic cells through the observation of morphological changes.
Mechanism of apoptosis induced by the addition of
Protochlamydia
We initially determined if either UV-treated or heat-treated
bacteria could induce apoptotic cell death. Both bacterial
treatments failed to induce cell death, indicating that viable
bacteria are required for this phenomenon to occur (Fig. 4C, D
and H). Whether the apoptosis is required for bacterial protein
synthesis remains undetermined. In addition, inoculation with
other viable chlamydiae [Parachlamydia acanthamoebae and Chlamydia
trachomatis (serovars D and L2)] did not cause apoptotic cell death
(Fig. 4 E–G), indicating that the observed apoptosis is specific to
the Protochlamydia in the chlamydiae used for this study. In
addition, because of short incubation period and observation at
low magnification, we could not distinguish inclusion formed by C.
trachomatis (D and L2) from cell nucleus.
We also assessed whether Protochlamydia could replicate and
grow in cultured HEp-2 cells using the previously established AIU
assay [26]. No increase in the number of bacterial infectious
progenies was observed in the cultures, regardless of the treatment
and washing to ensure bacterial attachment to the cells (Fig. 5A).
This indicated that an increase of bacterial infectious progenies
was not required for the induction of this apoptosis. Furthermore,
although bacteria were not observed within the cells throughout
the 24 h incubation (data not shown), at 5 days after incubation,
the bacterial signal associated with fluorescent in situ hybridization
(FISH) staining was barely observed inside the cells, regardless of
apoptosis (Fig. 5B and C), suggesting that a role of bacterial uptake
in the cell death induction may be minimal. However, the
treatment with cytochalacin D, which is a critical inhibitor for
pathogenic chlamydial invasion [27,28], slightly inhibited the
prevalence of dead cells (Fig. 5D), implying that the bacterial entry
may be in part associated with this apoptosis. Further study should
be needed to clarify this issue.
Consequently, we assessed whether bacterial attachment to the
cells is required for the observed cell death, by using a Transwell
assay mounting membrane filter with a 0.45 mm-pore size,
through which the bacteria could not pass. Apoptosis was induced
in cells that were mixed with Protochlamydia in the lower space of
the Transwell. In contrast, the cells cultured without Protochlamydia
in upper space of Transwell did not develop any morphological
changes indicative of apoptosis (Fig. 6). We also assessed the
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30270Figure 1. HEp-2 cell death induced by the addition of Protochlamydia.A ) Representative images showing Time-course changes of cell death
in HEp-2 cells after the addition of Protochlamydia (MOI 90). Cell death was estimated through the observation of nuclear morphological changes
with DAPI staining under a fluorescent microscope. Enlarged images (white square) show typical morphological changes with blebbing and
segmented nucleus indicating cell death. B) The ability of Protochlamydia to infect amoebae (A. castellanii C3). Infectious ability was estimated using
FISH staining [24]. Green, eukaryotic 18S rRNA. Yellow, specific Protochlamydia signals. Magnification,6100. C) Morphological changes of HEp-2 cells
after the addition of Protochlamydia (MOI 90), estimated using light microscopy at 24 h after incubation. Cells in the presence of the bacteria
exhibited morphological changes indicative of apoptosis, including rounding and detachment (See right panel).
doi:10.1371/journal.pone.0030270.g001
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PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30270Figure 2. Cell death in HEp-2 cells induced by the addition of Protochlamydia is apoptosis. Apoptotic cell death after the addition of
Protochlamydia (MOI 90) was estimated using the TUNEL assay (A, B) and DAPI staining (experiments with caspase inhibitors) (C, D). Staurosporine
(10 mM) was used as a positive control to induce apoptosis. A) Representative images of apoptotic cells with phase contrast images at 24 h after
incubation. Green, apoptotic cells. Magnification, 6100. B) The prevalence of apoptotic cells estimated by TUNEL assay with time-course changes.
The percentage of apoptotic cells was measured under a microscope by counting at least 200 cells in three random fields for each culture sample.
The data shown represent the means + standard deviations (error bars) (SD), obtained from at least three independent experiments performed in
triplicate. *, p,0.05; significantly different from each data at immediately (0 h) after incubation. C) The prevalence of cells with condensed chromatin
with time-cause changes in the presence or absence of the inhibitior, Z-VAD-FMK (general caspase inhibitor). The percentage of the cells was
measured under a microscope by counting at least 200 cells in three random fields for each culture sample. The data shown represent the means +
SD, obtained from at least three independent experiments performed in triplicate. *, p,0.05; significantly different from each data at immediately
(0 h) after incubation. D) The prevalence of cells with condensed chromatin at 24 h after incubation in the presence or absence of the inhibitor, Z-
DEVE-FMK (specific caspase-3 inhibitor). The data shown represent the means + SD, obtained from at least three independent experiments performed
in triplicate. *, p,0.05; significantly different from each data without the treatment.
doi:10.1371/journal.pone.0030270.g002
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with apoptosis. However, supernatants from HEp-2 cells with
bacterial induced apoptosis did not produce any morphological
changes on newly prepared HEp-2 cells (Fig. 6), and were similar
to control cells without bacteria. Since the influence of a few
amoebae cells contaminating the bacterial stock could not be ruled
out, these amoebae were eliminated with low-speed centrifugation
before being tested. Regardless of low-speed centrifugation, the
prevalence of apoptosis in HEp-2 cells did not change, and
moreover, the addition of amoebal lysate to the culture had no
affect on morphological changes in the HEp-2 cells (Fig. 7). This
demonstrated that there was no association between the amoebae
and apoptosis.
We also assessed if either the EB or RB form is responsible for
inducing apoptosis. The prevalence of apoptosis in HEp-2 cells
mixed with EB was significantly higher than that with RB (Fig. 7).
A slight increase in prevalence was observed when RB were added
to cultured cells because of the effect of contamination with a few
EB. Thus, we concluded that Protochlamydia EB, but not RB, could
induce apoptosis. The attachment of viable bacteria to the cells,
but not an increase of bacterial infectious progenies, is also
required for the apoptosis.
Effect of Protochlamydia on survival of primary cells,
human PBMCs
Because human immortal HEp-2 cells do not exhibit the traits
of human primary cells, we further examined whether Proto-
chlamydia could also induce cell death in primary human PBMCs
with or without activation, which were prepared from the blood of
five donors. Cell death did not occur in any of the PBMCs
regardless of activation, although staurosporine clearly induced
cell death in these cells [Fig. 8 (estimated by trypan blue exclusion
assay), and Fig. S3 (estimated by DAPI staining)].
Discussion
It is increasingly evident that the biological and genomic traits of
Protochlamydia are unique when compared with other bacterial
pathogens such as the pathogenic chlamydiae. In particular, the
Protochlamydia UWE25 genome was reported by Horn et al., [10] to
be approximately twice as large as the genomes of any other
pathogenic chlamydiae investigated, including C. trachomatis or C.
pneumoniae. In their study, only a few pseudogenes and genome
remnants were detected, which were mostly associated with the
transposase gene. This indicated that the genome of Protochlamydia
is not in the process of becoming smaller but has stabilized at
approximately 2.4 Mb [10]. In contrast, pathogenic chlamydiae
have a reduced genomic size because they inhabit in a more
homeostatic niche than that of Protochlamydia, which is exposed to
fluctuating environmental conditions in its amoebal host [10].
Therefore, Protochlamydia is likely to have retained many functional
molecules, which the pathogenic chlamydiae have lost as a
consequence of adapting to a stable host environment. Therefore,
the potential of Protochlamydia to induce apoptosis within human
immortal cells is of interest, as it offers new insights into host-
parasite relationships, and moreover, contributes to the develop-
Figure 3. Representative TEM images of HEp-2 cells treated with Protochlamydia or staurosporine. Cells were cultured with bacteria
adjusted at MOI 90 or staurosporine for 6 h, and then fixed. A) Negative control cells without any treatment. B) Cells treated with staurosporine
(10 mM). C and D) Representative images of HEp-2 cells treated with the bacteria.
doi:10.1371/journal.pone.0030270.g003
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PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e30270Figure 4. Viable Protochlamydia induced apoptosis. Cells were cultured with or without the bacteria adjusted at MOI 90 [or either heat- or UV-
killed bacteria (equivalent MOI 90)] or other chlamydiae for 24 h, and then cell morphological changes were also estimated by DAPI staining. The
representative images were captured at 24 h after incubation. Magnification,6200. A) Negative control cells without any treatment. B) Cells treated
with viable bacteria. C) Cells treated with heat-killed bacteria. D) Cells treated with UV-killed bacteria. E, F and G) Cells treated with other viable
chlamydiae adjusted at MOI 90 [C. trachomatis D (E), C. trachomatis L2 (F) and P. acanthamoebae (G)]. H) Time-course changes in the prevalence of
apoptotic cells. The data shown represent the means + SD, obtained from at least three independent experiments performed in triplicate. *, p,0.05;
significantly different from each data immediately (0 h) after incubation.
doi:10.1371/journal.pone.0030270.g004
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pathogens, through activation of the cells encountered unknown
proteins that still continued to be retained in Protochlamydia, but has
been lost in pathogenic chlamydiae.
While further study is needed to determine the mechanism by
which Protochlamydia induces apoptosis in human immortal HEp-2
cells, it is clear that the attachment of viable bacteria is necessary
and that an increase of bacterial infectious progenies within cells is
not required. Genome sequence data for Protochlamydia UWE25
suggests no association of the LPS endotoxin with cell death,
because it lacks the gene relating to LPS synthesis [10]. Dead
bacteria completely lost the ability to induce apoptosis, indicating
Figure 5. Changes of the number of bacterial infectious progenies within and without the cells, and effect of cytochalasin D on the
induction of apoptosis. A) Number of bacterial infectious progenies in the cultures. After mixing with the bacteria, cells with or without washing
were incubated for up to 5 days. The Bacterial numbers were estimated by the method described previously [26]. The data shown represent the
means 6 SD, obtained from at least three independent experiments performed in triplicate. See the Materials and Methods (Cell cultures inoculated
with bacteria). B) C) Representative FISH images of surviving cells (B) and apoptotic cells (C) 5 days after incubation. Bacteria were rarely observed
within the cells, regardless of apoptosis or not. Green indicates eukaryotic18S rRNA and yellow indicates specific Protochlamydia signals. Z, z-axis; *,
specific signal of the bacteria detected inside the cells. D) Effect of cytochalacin D on the cell death with the bacteria. The data shown represent the
means + SD, obtained from at least three independent experiments performed in triplicate. *, p,0.05; significantly different from bacteria alone at
each time point.
doi:10.1371/journal.pone.0030270.g005
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incapable of inducing apoptosis. Although Protochlamydia survival
under extracellular conditions requires further investigation,
support for our results is provided by recent work showing the
long-term extracellular activity of chlamydial EB [29,30].
While the mechanism by which Protochlamydia induces apoptosis
is currently unknown, it is possible that dedicated effectors
molecules secreted by the bacterial cytoplasm might contribute
to the observed cell death. Previous research of the bacterial
genome indicates the conservation of two types of secretion
machines, type III and type IV [31], although the associated
effectors molecules have yet to be characterized. It is well known
that C. trachomatis injects a variety of proteins into its host cells to
ensure the survival of this pathogen. Among them, inclusion
membrane proteins (Incs) are of particular interest. Even though
up to 70–90 Incs proteins are predicted for chlamydial genomes,
only a few of these proteins have been characterized beyond their
localization to the inclusion membrane [32,33,34,35]. A recent
study demonstrated that Protochlamydia UWE25 possessed multiple
functional Incs transferred on inclusion membrane, which might
be responsible for fusion of chlamydial inclusions and host cellular
vesicles containing lipid and metabolites [36]. Since known Inc
proteins do not share a sequence homology, it is possible that some
unknown proteins have a detrimental effect on host cells, such as
apoptosis.
Recent proteomic analysis has proposed a model of the P.
amoebophila outer membrane, indicating the presence of consider-
ably high amounts of putative lipoproteins [37]. Such bacterial
lipoproteins have a wide variety of functions and can activate
several human cell types; for example, mycoplasma lipoprotein
can activate cellular immune response via toll-like receptor,
followed by NF-kB activation with cross-linkage leading to cell
Figure 6. Induction of apoptosis requires the attachment of bacteria to HEp-2 cells. HEp-2 cells were cultured to both upper and lower
chambers in Transwells. Cells in the upper chamber were subsequently inoculated with bacteria (MOI 90). A) Representative images of DAPI staining
at 24 h after incubation. Magnification, 6200. B) Time-course changes of the percentage of apoptotic cells. The data shown represent the means +
SD, obtained from at least three independent experiments performed in triplicate. *, p,0.05; significantly different from each data immediately (0 h)
after incubation.
doi:10.1371/journal.pone.0030270.g006
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outer membrane are associated with apoptosis, although their
active translocation mechanism is currently unknown.
Previous research indicated that P. acanthamoebae, a member of
the environmental chlamydiae, could induce apoptosis in human
macrophages [20]. However, in our study P. acanthamoebae did not
induce apoptosis in HEp-2 immortal cells. Such disparity may be
associated with differences in culture conditions or cell line
characteristics. In addition, individual environmental chlamydiae
species have evolved into amoebae living into domestic area,
Figure 7. Enriched EB, but not RB or amoebal components, induced apoptosis in HEp-2 cells. A) Representative images showing that
only EB (MOI 90), but not RB (equivalent MOI 90) or amoeba components, induced apoptosis at 24 h after incubation. Magnification,6200. B) Time-
course changes of the percentage of apoptotic cells. The data shown represent the means + SD, obtained from at least three independent
experiments performed in triplicate. *, p,0.05; significantly different from each data immediately (0 h) after incubation.
doi:10.1371/journal.pone.0030270.g007
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differs from the others, regardless of same species. Therefore, it
could not deny that intraspecific variations within certain
environmental chlamydiae might also reflect the difference in
results.
Although the reasons as to why PBMCs did not succumb to
bacterial induced apoptosis remain unclear, it is easily thought that
intracellular activation against Protochlamydia in immortal cells may
differ from that in primary PBMCs; in fact it is well known that
immortal cells such as cancer cells display increased proliferation
with altered homeostasis via changes of various cellular functions
as compared with primary cells. Based upon these, we would like
to propose the following explanation: Immortal cells have evolved
the ability to undergo rapid genome replication, regardless of
limited in vitro culture conditions, when compared with normal
primary cells that have been freshly collected from tissues or blood.
Figure 8. Cell death did not occur in PBMCs regardless of activation with PMA and ionomycin. A) Representative DAPI staining images
showing that the bacteria induced cell death in immortal Jurkat cells, but not in primary PBMCs. Data was estimated at 24 h after incubation.
Magnification,61,000. B and C) Time-course changes of the percentage of dead PBMCs with (C) or without (B) PMA and ionomycin. PBMC cell death
prevalence was estimated using a trypan blue exclusion assay. The plot shown represents the mean value of the data from individual donors
performed in duplicate. The averages in parentheses at each time point are compared. *, p,0.05; significantly different from each average for the
‘‘without treatment group’’ at each of the time points after incubation.
doi:10.1371/journal.pone.0030270.g008
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bacteria is much bigger to immortal cells than that to primary
cells, implying that the treatment with Protochlamydia could
selectively cause cell death on cancer cells. Further study is
needed to verify this idea, which can potentially be used in the
development a novel drug that is specific and effective against
cancer cells.
In conclusion, for the first reported time we have demonstrated
that the amoebal endosymbiont Protochlamydia can induce
apoptosis in a human-immortal HEp-2 cell line, but not in
PBMCs. Thus, this endosymbiont has potential as a useful
biological tool for elucidating novel host-parasite relationships.
Methods
Bacteria stocks and assessment of bacterial numbers
Protochlamydia used in this study was identified as an environ-
mental amoebae endosymbiont [16SrRNA sequence: AB506679
(99.2% identities against Protochlamydia UWE25 16SrRNA se-
quence), and were maintained within infected R18 amoebae
(genotype T4), found in environmental Acanthamoeba strains
isolated from a river of Sapporo city, Japan [24,25]. Briefly, the
infected cells were harvested and disrupted by freeze thawing.
After centrifugation at 1806 g for 5 min to remove cell debris,
bacteria were concentrated by high-speed centrifugation at 8006g
for 30 min. The bacterial pellet was resuspended in sucrose-
phosphate-glutamic acid buffer containing 0.2 M sucrose, 3.8 mM
KH2PO4, 6.7 mM Na2HPO4 and 5 mM L-glutamic acid
(pH 7.4), and then stored at 280uC until needed. Killed bacteria
were prepared by UV exposure (15 W, 5 cm, 3 h) and heat
treatment (95uC, 30 min). EB-enriched and RB-enriched fractions
were also obtained from the bacterial stocks using ultra-high speed
centrifugation with percoll (Sigma, St. Louis, MO) density gradient
at 10,0006g for 1 h [40]. The number of infective Protochlamydia
progeny (EB) was determined with an amoeba-infectious unit
(AIU) assay, using a co-culture of the amoebae, established
previously [26]. Briefly, each sample containing viable Protochla-
mydia was serially diluted from 100–10
27 with PYG broth and
incubated with A. castellanii C3 (see below ‘‘Amoebae and human cells’’)
(10
4 or 10
5 per well) in PYG broth with or without cycloheximide
(200 mg/ml) in 96-well plates for 2 days. The infection rate of
Protochlamydia to amoebae (amoeba-infectious dose, AID) in each
well was determined by microscopy at a magnification of 1006,
following DAPI staining. Ten fields were randomly selected for
this assessment. The AIDs for a sample were plotted as a logistic
sigmoid dilution curve using statistical software (KaleidaGraph
3.6; Hulinks, Tokyo, Japan). The formula logically draws a specific
sigmoid curve via statistical software and shows a dilution rate
corresponding to the mid-value of the amoeba-infectious rate
(AID50). Finally, the viable bacterial numbers in cultures, defined
as AIU, can be determined based on the value of AID50. The
number of RB was adjusted under a chtoatometer. To assess the
influence of amoebal components or whole amoeba on apoptosis,
amoebal lysates prepared from C3 amoebae (approximately 10
6
cells) by freeze-thawing and the bacterial solution, from which
amoebae were eliminated by low-speed centrifugation (2006g,
10 min), were also used for this study. Parachlamydia acanthamoebae
[Bn9 (ATCC VR-1476)] was purchased from American Type
Culture Collection (Manassas, VA). The bacteria were propagated
in the amoeba cell culture system in the same way of Protochlamydia.
Also, C. trachomatis 434/Bu (LGV: serovar L2) and UX-7 (serovar
D) were purchased from ATCC. Bacteria were propagated in a
HEp-2 cell culture system as described previously [29].
Amoebae and human cells
Free-living amoebae, A. castellanii C3 (ATCC 50739), was
purchased from the American Type Culture Collection, and used
to assess the bacterial infectious progenies by AIU assay. As
mentioned above, R18 amoebae harboring endosymbiotic Proto-
chlamydia that were isolated from a natural environment were also
used to prepare bacterial stocks. Both amoebae were maintained
in PYG broth [0.75% (w/v) peptone, 0.75% (w/v) yeast extract
and 1.5% (w/v) glucose] at 30uC [26]. Immortal cells [Epithelial
cell line cells (HEp-2, Vero cells), immune cells (THP-1, Jurkat
cells)] and primary PBMCs prepared from whole blood, provided
by healthy volunteers, using density gradient centrifugation with
Histopaque (Sigma) were used for assessment of cell death.
Informed consent with written was obtained from all volunteers in
this study, and the study was approved by the ethics committee of
Faculty of Health Sciences, Hokkaido University.
Cell cultures inoculated with bacteria
Immortal cells (2610
5 cells) and PBMCs (5610
5 cells) were
cultured with or without bacteria adjusted at MOI 10–100 or with
staurosporine (10 mM) (Sigma) as a positive control for the
induction of apoptosis, for up to 24 h (for HEp-2 cells) or 5 days
(for PBMCs) at 37uCi n5 %C O 2 in DMEM (for HEp-2, Vero) or
RPMI medium (for THP-1, Jurkat, PBMCs), containing 10%
heat-inactivated fetal calf serum. Immortal cells and PBMCs were
also cultured in the presence or absence of the bacteria with or
without Z-VAD-FMK (100 mM) (general caspase inhibitor)
(Promega, Madison, WI), Z-DEVE-FMK (specific caspase-3
inhibitor) (100 mM) (R&D Systems, Minneapolis, MN), or
cytochalasin D (1 mM) (Sigma). In some experiment, HEp-2 cells
were cultured in a Transwell (pore size, 0.45 mm), to prevent the
direct attachment of bacteria. PBMCs activated with phorbol 12-
myristate 13-acetate (PMA) (25 ng/ml) (Sigma) and ionomycin
(1 mg/ml) (Sigma) were also used for this study. No cytotoxicity of
these drugs at working concentration in the cells was confirmed.
Assessment of cell death
Phenotypic alternation of the human cells was assessed using
DAPI staining, TEM and the TUNEL assay, according to the
classification method previously described by Kroemer et al [14].
Cell death of PBMCs was also estimated using a trypan blue
exclusion assay, in addition to assessing changes of nuclear
morphology by DAPI staining. TUNEL assays were performed
using a commercial in situ apoptosis detection kit (Takara, Shiga,
Japan), according to the manufacturer’s protocol. Morphological
analysis with TEM was performed according to the previously
described method [16]. In brief, bacteria within cultures were
immersed in a fixative containing 3% glutaraldehyde in 0.1 M
PBS pH 7.4, for 24 h at 4uC. After a brief wash with PBS, bacteria
were processed for alcohol dehydration and embedded in Epon
812. Ultrathin sections of the cells were stained with lead citrate
and uranium acetate before viewing by TEM (Hitachi H7100;
Hitachi, Tokyo, Japan).
Statistical analysis
Comparison of bacterial numbers in the in vitro experiment was
assessed using an unpaired t-test. A p-value of less than 0.05 was
considered significant.
Supporting Information
Figure S1 Representative images (A) and numbers of
dead cells (B) in HEp-2 cell cultures induced by the
addition of Protochlamydia dependent upon MOI. Cells
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100 for up to 24 h. The number of dead cells was estimated using
DAPI staining. The data shown represent the means + SD,
obtained from at least three independent experiments performed
in triplicate. *, p,0.05; significantly different from each data for
the ‘‘without bacteria’’.
(TIF)
Figure S2 Representative images (A) and numbers of
dead cells (B) in either Vero, THP-1, or Jurkat cells,
induced by the addition of Protochlamydia. Cells were
cultured with or without bacteria (MOI 90) or staurosporine for up
to 24 h. The data shown represent the means + SD, obtained from
at least three independent experiments performed in triplicate. *,
p,0.05; significantly different from each data for the ‘‘(-)’’ at
immediately (0 h) after incubation.
(TIF)
Figure S3 Representative images of cells with con-
densed chromatin (A) and the prevalence of dead cells
in PBMC cultures prepared from three donors (donor 1–
3; See the Fig. 8) in the presence or absence of the
bacteria (MOI 90) or staurosporine, with or without
PMA and inomycin for up to 3 days. A) Representative DAPI
staining images showing that the bacteria induced cell death in
PBMCs only limited with staurosporine. The data were estimated
at 24 h after incubation. Magnification, 61,000. B) The
percentage of dead cells in PBMCs. The prevalence of dead cells
was estimated using DAPI staining. The data shown represent the
means + SD, obtained from at least three independent
experiments performed in triplicate. *, p,0.05; significantly
different from each data for the ‘‘(-)’’ at each time point.
(TIF)
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